Today: 13 November 2025
Subscribe
Browse Tag

stock update

Billion-Dollar Brawl: Novo Nordisk and Pfizer Clash in High-Stakes Obesity Drug Takeover

Novo Nordisk (NVO) Today — Nov. 12, 2025: WeightWatchers to Offer Wegovy Pill, Canada Eyes Ozempic Copies, and the Latest Stock Move

Published: November 12, 2025 Summary: WeightWatchers says it will sell Wegovy in a pill once launched WeightWatchers (WW) plans to carry Novo Nordisk’s oral Wegovy, pending U.S. approval, leaning into consumer preference for pills over injections and differentiating from rivals pushing cheaper copycat products. The move follows the company’s bankruptcy exit and dovetails with a broader U.S. pricing framework announced last week that targets lower monthly costs for GLP‑1 therapies. Reuters Why it matters: Convenience could further expand GLP‑1 adoption. The White House’s fact sheet outlines headline pricing—$150/month for starter doses of weight‑loss pills through TrumpRx if approved, and $245/month
12 November 2025
 ·  ·  ·  ·  · 
Fortinet (FTNT) slips on soft Q4 outlook after Q3 beat; price targets trimmed as company unveils “Secure AI Data Center” — Nov. 6, 2025

Fortinet (FTNT) slips on soft Q4 outlook after Q3 beat; price targets trimmed as company unveils “Secure AI Data Center” — Nov. 6, 2025

Earnings snapshot: strong quarter, but guidance cools sentiment What happened: Fortinet’s September‑quarter (Q3 FY25) revenue rose ~14% to ~$1.72B with adjusted EPS at $0.74 (vs. ~$0.63 expected). Billings—a forward demand proxy—also climbed ~14% to ~$1.81B. After the report, investors focused on the softer Q4 guide, which ran a touch below consensus and drove the shares lower in late trading. Investors Profitability: Management cited a record Q3 non‑GAAP operating margin of ~36.9% (GAAP operating margin also a third‑quarter record, per the release). That efficiency was a bright spot despite the cautious near‑term revenue view. Investing.com+1 Q4 & FY25 outlook: Fortinet now
6 November 2025
 ·  ·  ·  ·  · 
Crown Electrokinetics (CRWV/CRKN) Surges Amid Takeover Buzz – Key Facts & Analysis (Sept 30, 2025)

Crown Equity Holdings (OTC:CRWE) Surges Into Spotlight: Joint Ventures Spark Speculation – Stock Update (1:20 PM ET Sept 2025)

Citations in the summary above: company business summary tipranks.com, market stats tipranks.com tipranks.com, financials mlq.ai, press releases crwepressrelease.com crwepressrelease.com crwepressrelease.com crwepressrelease.com, analyst commentary newswireindiaonline.com newswireindiaonline.com, and regulatory filings crownequityholdings.com crwepressrelease.com crwepressrelease.com. Company Profile and Stock Overview Crown Equity Holdings, Inc. (CRWE) describes itself as “an online multi-media publisher” providing advertising, branding, and marketing services worldwide tipranks.com. It operates in the digital/media consulting space (after originally being named Micro Bio-Medical Waste Systems, Inc. before 2006). The company also touts its developing CRWE WORLD platform for news and business launches. Crown Equity is traded over-the-counter (OTCPink) and as of Sept 30, 2025
30 September 2025
 ·  ·  ·  ·  · 
Go toTop